documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
797 rows where agency_id = "FDA", document_type = "Notice" and posted_year = 2010 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2010-N-0118-0005 | FDA | FDA-2010-N-0118 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Imported Food under 2002 Public Health Security and Bioterrorism Preparedness and Response Act of 2002 | Notice | N-Notice | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2010-12-30T14:44:54Z | 2010-32946 | 0 | 0 | 0900006480bc26ef | |
| FDA-2010-N-0356-0004 | FDA | FDA-2010-N-0356 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Designated New Animal Drugs for Minor Use and Minor Species | Notice | N-Notice | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2010-12-30T14:39:28Z | 2010-32948 | 0 | 0 | 0900006480bc26eb | |
| FDA-2010-N-0001-0163 | FDA | FDA-2010-N-0001 | Meetings: Pulmonary-Allergy Drugs Advisory Committee | Notice | NM-Notice of Meeting | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2010-12-29T15:23:00Z | 2010-32735 | 0 | 0 | 0900006480bc1b9a | |
| FDA-2010-N-0640-0001 | FDA | FDA-2010-N-0640 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Data To Support Food and Nutrition Product Communications, as Used by Food and Drug Administration | Notice | N-Notice | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2011-03-01T04:59:59Z | 2010-12-29T15:29:12Z | 2010-32739 | 0 | 0 | 0900006480bc1bc0 |
| FDA-2010-N-0198-0003 | FDA | FDA-2010-N-0198 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notification | Notice | N-Notice | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T16:44:38Z | 2010-32508 | 0 | 0 | 0900006480bc11ca | |
| FDA-2010-P-0326-0003 | FDA | FDA-2010-P-0326 | Determination that Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: TRANDATE (Labetalol Hydrochloride) Tablets, 300 Milligrams and 400 Milligrams | Notice | N-Notice | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T16:37:57Z | 2010-32507 | 0 | 0 | 0900006480bc11ac | |
| FDA-2010-N-0001-0161 | FDA | FDA-2010-N-0001 | Meetings: Anesthetic and Life Support Drugs Advisory Committee | Notice | NM-Notice of Meeting | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T16:11:53Z | 2010-32591 | 0 | 0 | 0900006480bc0c47 | |
| FDA-2010-N-0001-0162 | FDA | FDA-2010-N-0001 | Request for Nominations: Voting and Non-Voting Members of Public Advisory Committees or Panels | Notice | N-Notice | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T16:28:32Z | 2010-32624 | 0 | 0 | 0900006480bc1153 | |
| FDA-2010-N-0447-0003 | FDA | FDA-2010-N-0447 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Third Party Review Program Under the Food and Drug Administration Modernization Act | Notice | N-Notice | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2011-03-14T20:37:01Z | 2010-32603 | 0 | 0 | 0900006480bc0c82 | |
| FDA-2010-N-0001-0160 | FDA | FDA-2010-N-0001 | Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting | Notice | NM-Notice of Meeting | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2010-12-27T14:48:01Z | 2010-32367 | 0 | 0 | 0900006480bc03c3 | |
| FDA-2010-N-0001-0159 | FDA | FDA-2010-N-0001 | Oncologic Drugs Advisory Committee; Cancellation | Notice | N-Notice | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2010-12-27T14:44:55Z | 2010-32413 | 0 | 0 | 0900006480bc0306 | |
| FDA-2010-D-0575-0001 | FDA | FDA-2010-D-0575 | Draft Compliance Policy Guide Sec. 510.800 Beverages, Serving Size Labeling; Availability | Notice | NAD-Notice of Availability of Data | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2011-02-23T04:59:59Z | 2010-12-23T14:41:09Z | 2010-32249 | 0 | 0 | 0900006480bbe9be |
| FDA-2010-N-0266-0007 | FDA | FDA-2010-N-0266 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Study of Clinical Efficacy Information in Professional Labeling, etc.; Correction | Notice | NCR-Notice of Correction | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2010-12-23T15:27:48Z | 2010-32278 | 0 | 0 | 0900006480bbea66 | |
| FDA-2010-N-0631-0001 | FDA | FDA-2010-N-0631 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Updating Labeling for Susceptibility Test Information in Systemic Antibacterial Drug Products, etc. | Notice | N-Notice | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2011-02-23T04:59:59Z | 2010-12-23T15:30:54Z | 2010-32276 | 0 | 0 | 0900006480bbea69 |
| FDA-2009-D-0466-0008 | FDA | FDA-2009-D-0466 | Compliance Policy Guide; Dairy Products; Availability: Microbial Contaminants and Alkaline Phosphatase Activity | Notice | NAD-Notice of Availability of Data | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2024-11-07T22:30:06Z | 2010-32232 | 1 | 0 | 0900006480bbe9e4 | |
| FDA-2010-N-0074-0003 | FDA | FDA-2010-N-0074 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments, etc. | Notice | N-Notice | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2010-12-23T14:16:46Z | 2010-32277 | 0 | 0 | 0900006480bbe9b2 | |
| FDA-2010-N-0368-0007 | FDA | FDA-2010-N-0368 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Pet Event Tracking Network -- State, Federal Cooperation to Prevent Spread of Pet Food Related Diseases | Notice | N-Notice | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2011-01-25T04:59:59Z | 2010-12-23T14:34:11Z | 2010-32275 | 0 | 0 | 0900006480bbe9b3 |
| FDA-2004-D-0298-0005 | FDA | Compliance Policy Guide Sec. 400.210 Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs, Availability FDA-2004-D-0298 | Compliance Policy Guides: Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs | Notice | NEC-Notice of Extension | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2024-11-07T22:30:10Z | 2010-32274 | 1 | 0 | 0900006480bbea44 | |
| FDA-2010-N-0001-0158 | FDA | FDA-2010-N-0001 | Meetings: Advisory Committees; Tentative Schedule for 2011 | Notice | N-Notice | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2010-12-21T14:54:16Z | 2010-31961 | 0 | 0 | 0900006480bbcc5e | |
| FDA-2010-N-0626-0001 | FDA | FDA-2010-N-0626 | Abbott Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for MERIDIA | Notice | Withdrawal | 2010-12-21T05:00:00Z | 2010 | 12 | 2018-02-26T16:00:33Z | 2010-31986 | 0 | 0 | 0900006480bbcc3f | ||
| FDA-2010-E-0042-0005 | FDA | FDA-2010-E-0042 | Regulatory Review Periods for Purposes of Patent Extensions; Determinations: LIVALO | Notice | N-Notice | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2011-02-19T04:59:59Z | 2010-12-20T16:01:56Z | 2010-31847 | 0 | 0 | 0900006480bba8e1 |
| FDA-2010-N-0420-0004 | FDA | FDA-2010-N-0420 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Testing Communications on FDA-Regulated Products Used in Animals | Notice | N-Notice | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2011-01-20T04:59:59Z | 2010-12-20T15:38:33Z | 2010-31891 | 0 | 0 | 0900006480bba849 |
| FDA-2010-N-0528-0001 | FDA | FDA-2010-N-0528 | Unapproved Animal Drugs | Notice | N-Notice | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2011-02-19T04:59:59Z | 2010-12-20T15:22:13Z | 2010-31889 | 0 | 0 | 0900006480bba831 |
| FDA-2010-E-0030-0005 | FDA | FDA-2010-E-0030 | Regulatory Review Periods for Purposes of Patent Extensions; Determinations: FOLOTYN | Notice | N-Notice | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2011-02-19T04:59:59Z | 2010-12-20T15:54:26Z | 2010-31846 | 0 | 0 | 0900006480bba892 |
| FDA-2010-N-0001-0157 | FDA | FDA-2010-N-0001 | Meetings: Defense Advanced Research Projects Agency and Food and Drug Administration Expanding in Vivo Biomarker Detection Devices Workshop | Notice | NM-Notice of Meeting | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T15:47:37Z | 2010-31811 | 0 | 0 | 0900006480bba880 | |
| FDA-2010-N-0627-0001 | FDA | FDA-2010-N-0627 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application for Food and Drug Administration Approval to Market New Drug | Notice | N-Notice | 2010-12-17T05:00:00Z | 2010 | 12 | 2010-12-17T05:00:00Z | 2011-02-16T04:59:59Z | 2010-12-17T14:36:03Z | 2010-31693 | 0 | 0 | 0900006480bb91f0 |
| FDA-2010-N-0235-0001 | FDA | FDA-2010-N-0235 | Debarment Orders: Ehigiator O. Akhigbe | Notice | NFR-Notice of Final Rule | 2010-12-17T05:00:00Z | 2010 | 12 | 2010-12-17T05:00:00Z | 2010-12-17T14:31:06Z | 2010-31776 | 0 | 0 | 0900006480bb919d | |
| FDA-2010-D-0605-0001 | FDA | FDA-2010-D-0605 | Small Entity Compliance Guides; Availability, etc.: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements | Notice | NAD-Notice of Availability of Data | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2024-11-12T05:00:25Z | 2010-31613 | 1 | 0 | 0900006480bb8272 | |
| FDA-2001-E-0027-0020 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: ANGIOMAX | Notice | N-Notice | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2024-11-12T05:00:23Z | 2010-31583 | 1 | 0 | 0900006480bb825a | |
| FDA-2010-D-0616-0001 | FDA | FDA-2010-D-0616 | Draft Guidance for Industry; Availability: Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination | Notice | NAD-Notice of Availability of Data | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2011-02-15T04:59:59Z | 2010-12-15T22:26:14Z | 2010-31426 | 0 | 0 | 0900006480bb7048 |
| FDA-2010-N-0184-0007 | FDA | FDA-2010-N-0184 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study of Patient Information Prototypes | Notice | NAD-Notice of Availability of Data | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2011-01-15T04:59:59Z | 2010-12-15T21:58:54Z | 2010-31388 | 0 | 0 | 0900006480bb7010 |
| FDA-2010-N-0623-0001 | FDA | FDA-2010-N-0623 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Voluntary Cosmetic Registration Program | Notice | N-Notice | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2011-02-15T04:59:59Z | 2010-12-15T22:04:45Z | 2010-31386 | 0 | 0 | 0900006480bb7013 |
| FDA-2009-D-0008-0009 | FDA | FDA-2009-D-0008 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of Federal Food, Drug, and Cosmetic Act | Notice | N-Notice | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T22:16:59Z | 2010-31380 | 0 | 0 | 0900006480bb70ec | ||
| FDA-2010-N-0380-0002 | FDA | FDA-2010-N-0380 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Food and Drug Administration Rapid Response Surveys | Notice | N-Notice | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2011-01-15T04:59:59Z | 2010-12-15T21:54:50Z | 2010-31381 | 0 | 0 | 0900006480bb6f22 |
| FDA-2009-N-0360-0003 | FDA | FDA-2009-N-0360 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Public Health Notification Readership Survey | Notice | N-Notice | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T22:09:18Z | 2010-31387 | 0 | 0 | 0900006480bb7067 | ||
| FDA-2010-N-0418-0003 | FDA | FDA-2010-N-0418 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Institutional Review Boards | Notice | N-Notice | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T22:13:12Z | 2010-31389 | 0 | 0 | 0900006480bb70a6 | ||
| FDA-2010-E-0038-0005 | FDA | FDA-2010-E-0038 | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: SAMSCA | Notice | N-Notice | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2010-12-14T20:35:51Z | 2010-31298 | 0 | 0 | 0900006480bb6397 | |
| FDA-2009-E-0014-0006 | FDA | FDA-2009-E-0014 | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: FREESTYLE NAVIGATOR | Notice | N-Notice | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2010-12-14T20:43:14Z | 2010-31240 | 0 | 0 | 0900006480bb5eeb | |
| FDA-2010-E-0024-0005 | FDA | FDA-2010-E-0024 | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: VIBATIV | Notice | N-Notice | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2010-12-14T19:45:10Z | 2010-31250 | 0 | 0 | 0900006480bb6337 | |
| FDA-2010-E-0022-0005 | FDA | FDA-2010-E-0022 | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: VIBATIV | Notice | N-Notice | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2010-12-14T19:17:04Z | 2010-31250 | 0 | 0 | 0900006480bb5ecf | |
| FDA-2010-N-0618-0001 | FDA | FDA-2010-N-0618 | Statements of Organization, Functions and Delegations of Authority | Notice | N-Notice | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-15T22:21:20Z | 2010-31383 | 0 | 0 | 0900006480bb70c2 | ||
| FDA-2010-E-0037-0005 | FDA | FDA-2010-E-0037 | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: SAMSCA | Notice | N-Notice | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2010-12-14T16:49:55Z | 2010-31298 | 0 | 0 | 0900006480bb5ebd | |
| FDA-2010-N-0622-0001 | FDA | FDA-2010-N-0622 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Color Additive Certification Requests and Recordkeeping | Notice | 60 Day Proposed Information Collection | 2010-12-13T05:00:00Z | 2010 | 12 | 2010-12-13T05:00:00Z | 2011-02-12T04:59:59Z | 2017-03-17T14:13:33Z | 2010-31195 | 0 | 0 | 0900006480bb4ff1 |
| FDA-1976-N-0111-0001 | FDA | Food Additives and Animal Products, Recodification FDA-1976-N-0111 | Food and Drug Administration, Department of Health, Education, and Welfare; Recodification Editorial and Technical Amendments | Notice | N-Notice | 2010-12-13T05:00:00Z | 2010 | 12 | 2010-12-13T05:00:00Z | 2010-12-13T23:14:26Z | 0 | 0 | 090000648051dacf | ||
| FDA-2010-N-0389-0017 | FDA | FDA-2010-N-0389 | Meetings: Medical Device User Fee Program; Request for Notification of Patientand Consumer Advocacy Group Intentions to Participate | Notice | N-Notice | 2010-12-13T05:00:00Z | 2010 | 12 | 2010-12-13T05:00:00Z | 2010-12-13T15:25:18Z | 2010-31160 | 0 | 0 | 0900006480bb4fc1 | |
| FDA-2010-E-0040-0006 | FDA | FDA-2010-E-0040 | Deteermination of Regulatory Review Period for Purposes of Patent Extension; MULTAQ | Notice | N-Notice | 2010-12-10T05:00:00Z | 2010 | 12 | 2010-12-10T05:00:00Z | 2010-12-10T16:25:59Z | 0 | 0 | 0900006480bb3d90 | ||
| FDA-2010-N-0001-0156 | FDA | FDA-2010-N-0001 | Tobacco Products Scientific Advisory Committee; Notice of Meeting | Notice | GDL-Guidance | 2010-12-10T05:00:00Z | 2010 | 12 | 2010-12-10T05:00:00Z | 2010-12-10T16:30:50Z | 2010-31066 | 0 | 0 | 0900006480bb392a | |
| FDA-2005-D-0072-0005 | FDA | Draft Guidance on the Open Public Hearing, FDA Advisory Committee Meetings FDA-2005-D-0072 | Guidance for Public, FDA Advisory Committee Members, and FDA Staff; Availability: The Open Public Hearing at FDA Advisory Committee Meetings;Availability | Notice | NAD-Notice of Availability of Data | 2010-12-10T05:00:00Z | 2010 | 12 | 2010-12-10T05:00:00Z | 2024-11-07T22:28:26Z | 2010-31022 | 1 | 0 | 0900006480bb387e | |
| FDA-2009-E-0510-0012 | FDA | FDA-2009-E-0510 | Determination of Regulatory Review Period for Purposes of Patent Extension: COARTEM | Notice | N-Notice | 2010-12-10T05:00:00Z | 2010 | 12 | 2010-12-10T05:00:00Z | 2024-11-07T22:28:12Z | 2010-31074 | 1 | 0 | 0900006480bb3967 | |
| FDA-2010-E-0039-0006 | FDA | FDA-2010-E-0039 | Determination of Regulatory Review Period for Purposes of Patent Extension: MULTAQ | Notice | N-Notice | 2010-12-10T05:00:00Z | 2010 | 12 | 2010-12-10T05:00:00Z | 2010-12-10T16:20:27Z | 2010-31064 | 0 | 0 | 0900006480bb389f | |
| FDA-2010-E-0021-0005 | FDA | FDA-2010-E-0021 | Determinations of Regulatory Review Periods for Purposes of Patent Extension; SABRIL | Notice | N-Notice | 2010-12-09T05:00:00Z | 2010 | 12 | 2010-12-09T05:00:00Z | 2024-11-07T22:27:57Z | 2010-30995 | 1 | 0 | 0900006480bb2d85 | |
| FDA-2010-E-0044-0005 | FDA | FDA-2010-E-0044 | Determinations of Regulatory Review Periods for Purposes of Patent Extension; BEPREVE | Notice | N-Notice | 2010-12-09T05:00:00Z | 2010 | 12 | 2010-12-09T05:00:00Z | 2024-11-07T22:28:14Z | 2010-30991 | 1 | 0 | 0900006480bb2846 | |
| FDA-2010-E-0047-0003 | FDA | FDA-2010-E-0047 | Determination of Regulatory Review Period for Purposes of Patent Extension; ILARIS | Notice | N-Notice | 2010-12-09T05:00:00Z | 2010 | 12 | 2010-12-09T05:00:00Z | 2024-11-07T22:27:57Z | 2010-30992 | 1 | 0 | 0900006480bb2d66 | |
| FDA-2010-P-0177-0004 | FDA | FDA-2010-P-0177 | Determination That AUGMENTIN ‘125’ (Amoxicillin; Clavulanate Potassium) Chewable Tablet and Six Other AUGMENTIN (Amoxicillin; Clavulanate Potassium) Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | N-Notice | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2010-12-08T16:13:47Z | 2010-30622 | 0 | 0 | 0900006480bb20d9 | |
| FDA-2010-N-0602-0001 | FDA | FDA-2010-N-0602 | Biologies Price Competition and Innovation Act of 2009;Meetings: User Fee Program for Biosimilar and Interchangeable Biological Product Applications; Request for Notification of Stakeholer Intention to Participate | Notice | N-Notice | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2011-01-11T04:59:59Z | 2010-12-08T16:09:30Z | 2010-30713 | 0 | 0 | 0900006480bb1e4f |
| FDA-2010-N-0088-0003 | FDA | FDA-2010-N-0088 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Electronic Products; General Requirements | Notice | NAL-Notice of Approval | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2010-12-08T14:17:25Z | 2010-30555 | 0 | 0 | 0900006480bb0cf7 | |
| FDA-2010-N-0568-0006 | FDA | FDA-2010-N-0568 | Required Warnings for Cigarette Packages and Advertisements; Research Report | Notice | N-Notice | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2011-01-12T04:59:59Z | 2011-06-11T16:29:00Z | 2010-30685 | 0 | 0 | 0900006480bb0be7 |
| FDA-2010-P-0172-0005 | FDA | FDA-2010-P-0172 | Determinations that Drug Products Not Withdrawn from Sale for Reasons of Safety or Effectiveness: AUGMENTIN 125 (Amoxicillin; Clavulanate Potassium) Chewable Tablet and Six Other AUGMENTIN (Amoxicillin; Clavulanate Potassium) | Notice | N-Notice | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2010-12-07T17:42:31Z | 2010-30622 | 0 | 0 | 0900006480bb0c74 | |
| FDA-2010-N-0551-0001 | FDA | FDA-2010-N-0551 | Compliance Policy Guides; Withdrawals: Laser(s) as Medical Devices for Facelift, Wrinkle Removal, Acupuncture, Auricular Stimulation, etc. | Notice | NWL-Notice of Withdrawl | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2010-12-07T16:06:30Z | 2010-30679 | 0 | 0 | 0900006480bb0c03 | |
| FDA-2010-N-0316-0002 | FDA | FDA-2010-N-0316 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Adverse Event Pilot Program for Medical Products | Notice | N-Notice | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2011-01-07T04:59:59Z | 2010-12-07T16:43:53Z | 2010-30583 | 0 | 0 | 0900006480bb0c2a |
| FDA-2010-N-0550-0001 | FDA | FDA-2010-N-0550 | Withdrawals Of Guidance: Compliance Policy Guide Sec. 390.500 Definition of High-Voltage Vacuum Switch | Notice | NWL-Notice of Withdrawl | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2010-12-08T13:59:45Z | 2010-30677 | 0 | 0 | 0900006480bb0caf | |
| FDA-2010-N-0001-0154 | FDA | FDA-2010-N-0001 | Meetings: Third Annual Sentinel Initiative; Public Workshop | Notice | NM-Notice of Meeting | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2010-12-08T14:06:32Z | 2010-30562 | 0 | 0 | 0900006480bb0c93 | |
| FDA-2010-P-0275-0003 | FDA | FDA-2010-P-0275 | Determinations that Product Withdrawal From Sale Was Not for Reasons of Safety or Effectiveness: GLEEVEC (Imatinib Mesylate) Capsules, 50 Milligrams and 100 Milligrams | Notice | N-Notice | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2010-12-07T15:24:43Z | 2010-30570 | 0 | 0 | 0900006480bb0be6 | |
| FDA-2004-N-0056-0012 | FDA | Annual Guidance Agenda FDA-2004-N-0056 | Annual Guidance Agenda - Notice | Notice | N-Notice | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2011-01-19T13:30:11Z | 2010-30623 | 0 | 0 | 0900006480bb0c04 | |
| FDA-2010-N-0606-0001 | FDA | FDA-2010-N-0606 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Additional Listing Information for Medical Device Registration and Listing | Notice | N-Notice | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2011-02-08T04:59:59Z | 2010-12-08T14:31:55Z | 2010-30582 | 0 | 0 | 0900006480bb0c5c |
| FDA-2010-N-0083-0004 | FDA | FDA-2010-N-0083 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed | Notice | NAL-Notice of Approval | 2010-12-07T05:00:00Z | 2010 | 12 | 2010-12-07T05:00:00Z | 2010-12-08T14:20:57Z | 2010-30556 | 0 | 0 | 0900006480bb0c4c | |
| FDA-2010-N-0001-0152 | FDA | FDA-2010-N-0001 | Meetings: Oncologic Drugs Advisory Committee | Notice | NM-Notice of Meeting | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2010-12-06T16:46:45Z | 2010-30502 | 0 | 0 | 0900006480bafeac | |
| FDA-2000-N-0163-0023 | FDA | Bacterial Vaccines & Related Biological Products FDA-2000-N-0163 | Reclassifications of Category IIIA Biological Products, Bacterial Vaccines and Related Biological Products, etc.: Delmont Laboratories, Inc.; Denial of Request for Hearing and Revocation of License | Notice | NFR-Notice of Final Rule | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2010-12-06T17:22:07Z | 2010-30441 | 0 | 0 | 0900006480bafeaf | |
| FDA-2009-E-0584-0005 | FDA | FDA-2009-E-0584 | Determination of Regulatory Review Period for Purposes of Patent Extension: Besivance | Notice | N-Notice | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2010-12-08T16:21:28Z | 2010-30510 | 0 | 0 | 0900006480baff29 | |
| FDA-2010-N-0595-0001 | FDA | FDA-2010-N-0595 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Exports; Notification and Recordkeeping Requirements | Notice | N-Notice | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2011-02-05T04:59:59Z | 2010-12-06T16:36:03Z | 2010-30433 | 0 | 0 | 0900006480bafe8a |
| FDA-2010-E-0036-0004 | FDA | FDA-2010-E-0036 | Determination of Regulatory Review Period for Purposes of Patent Extension; STELARA | Notice | N-Notice | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2010-12-06T20:53:16Z | 2010-30512 | 0 | 0 | 0900006480bafc54 | |
| FDA-2010-E-0032-0004 | FDA | FDA-2010-E-0032 | Determination of Regulatory Review Period for Purposes of Patent Extension: Stelara | Notice | N-Notice | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2010-12-06T17:40:07Z | 2010-30512 | 0 | 0 | 0900006480baff07 | |
| FDA-2010-N-0001-0153 | FDA | FDA-2010-N-0001 | Meetings: Peripheral and Central Nervous System Drugs Advisory Committee | Notice | NM-Notice of Meeting | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2010-12-06T17:28:55Z | 2010-30501 | 0 | 0 | 0900006480bafed0 | |
| FDA-2009-D-0137-0025 | FDA | FDA-2009-D-0137 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry; Use of Serological Tests to Reduce Risk of Transmission of Trypanosoma cruzi Infection, etc. | Notice | 30 Day Proposed Information Collection | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2011-01-06T04:59:59Z | 2016-10-28T18:34:06Z | 2010-30404 | 0 | 0 | 0900006480bafe83 |
| FDA-2009-D-0137-0026 | FDA | FDA-2009-D-0137 | Guidance for Industry: Use of Serological Tests to Reduce Riskof Transmission of Trypanosoma cruzi Infection, etc. | Notice | Notice of Availability | 2010-12-06T05:00:00Z | 2010 | 12 | 2010-12-06T05:00:00Z | 2016-10-28T18:39:30Z | 2010-30405 | 0 | 0 | 0900006480baff0b | |
| FDA-2009-D-0533-0008 | FDA | FDA-2009-D-0533 | Guidance for Industry: Recommendations for Blood Establishments; Availability: Training of Back-UpPersonnel, Assessment of Blood Donor Suitability, and Reporting Certain Changes to an Approved Application | Notice | NAD-Notice of Availability of Data | 2010-12-03T05:00:00Z | 2010 | 12 | 2010-12-03T05:00:00Z | 2010-12-03T19:53:33Z | 2010-30388 | 0 | 0 | 0900006480bad6f5 | |
| FDA-1999-F-0056-0003 | FDA | National Fisheries Institute and the Louisiana Department of Agriculture FDA-1999-F-0056 | National Fisheries Institute; Filing of Food Additive Petition (FAP 9M4682) | Notice | NFL-Notice of Filing | 2010-12-03T05:00:00Z | 2010 | 12 | 2010-12-03T05:00:00Z | 2010-12-03T17:37:36Z | 0 | 0 | 09000064804a61c6 | ||
| FDA-2010-D-0566-0001 | FDA | FDA-2010-D-0566 | Draft Guidance for Industry on Residual Solvents in Animal Drug Products; Questions and Answers;Availability | Notice | NAD-Notice of Availability of Data | 2010-12-03T05:00:00Z | 2010 | 12 | 2010-12-03T05:00:00Z | 2011-02-02T04:59:59Z | 2010-12-03T17:35:27Z | 2010-30387 | 0 | 0 | 0900006480bad670 |
| FDA-2010-N-0597-0001 | FDA | FDA-2010-N-0597 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Index of Legally Marketed Unapproved New Animal Drugs for Minor Species | Notice | 60 Day Proposed Information Collection | 2010-12-03T05:00:00Z | 2010 | 12 | 2010-12-03T05:00:00Z | 2011-02-02T04:59:59Z | 2016-12-08T14:14:19Z | 2010-30335 | 0 | 0 | 0900006480bad543 |
| FDA-2010-N-0266-0005 | FDA | FDA-2010-N-0266 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Study of ClinicalEfficacy Information in Professional Labeling and Direct-to-Consumer Print Advertisements for Prescription Drugs | Notice | N-Notice | 2010-12-03T05:00:00Z | 2010 | 12 | 2010-12-03T05:00:00Z | 2011-01-04T04:59:59Z | 2010-12-03T17:25:33Z | 2010-30385 | 0 | 0 | 0900006480bad6f4 |
| FDA-2010-N-0001-0151 | FDA | FDA-2010-N-0001 | Meetings: Gastrointestinal Drugs Advisory Committee | Notice | NM-Notice of Meeting | 2010-12-02T05:00:00Z | 2010 | 12 | 2010-12-02T05:00:00Z | 2010-12-02T18:04:06Z | 2010-30274 | 0 | 0 | 0900006480babfeb | |
| FDA-2010-N-0603-0001 | FDA | FDA-2010-N-0603 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Animal Drug User Fees and Fee Waivers and Reductions | Notice | N-Notice | 2010-12-02T05:00:00Z | 2010 | 12 | 2010-12-02T05:00:00Z | 2011-02-01T04:59:59Z | 2010-12-02T17:58:10Z | 2010-30264 | 0 | 0 | 0900006480bac029 |
| FDA-2010-N-0182-0003 | FDA | FDA-2010-N-0182 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Procedures for Safe and Sanitary Processing and Importing of Fish and Fishery Products | Notice | NAL-Notice of Approval | 2010-12-02T05:00:00Z | 2010 | 12 | 2010-12-02T05:00:00Z | 2010-12-02T17:53:36Z | 2010-30277 | 0 | 0 | 0900006480babf74 | |
| FDA-2010-N-0001-0149 | FDA | FDA-2010-N-0001 | Food Advisory Committee; Notice of Meeting | Notice | NM-Notice of Meeting | 2010-12-01T05:00:00Z | 2010 | 12 | 2011-08-16T19:06:57Z | 2010-30187 | 0 | 0 | 0900006480baaef2 | ||
| FDA-2010-N-0001-0150 | FDA | FDA-2010-N-0001 | Workshops: Food Labeling | Notice | NM-Notice of Meeting | 2010-12-01T05:00:00Z | 2010 | 12 | 2010-12-01T05:00:00Z | 2010-12-01T20:48:06Z | 2010-30191 | 0 | 0 | 0900006480baaf41 | |
| FDA-2010-N-0576-0001 | FDA | FDA-2010-N-0576 | Requests for Supplemental Applications: Supplemental Funding under Food and Drug Administration'sConvener of Active Medical Product Surveillance Discussions | Notice | NI-Notice of Intent | 2010-11-30T05:00:00Z | 2010 | 11 | 2010-11-30T05:00:00Z | 2010-11-30T17:35:37Z | 2010-30054 | 0 | 0 | 0900006480ba953e | |
| FDA-2010-M-0519-0002 | FDA | FDA-2010-M-0519 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval | Notice | NAL-Notice of Approval | 2010-11-30T05:00:00Z | 2010 | 11 | 2010-11-30T05:00:00Z | 2010-11-30T17:29:06Z | 0 | 0 | 0900006480ba9673 | ||
| FDA-1996-M-0183-0001 | FDA | Home Access Health Corp.; PMA of the Home Access HIV-1 Test FDA-1996-M-0183 | Home Access Health Corp.; Premarket Approval of the Home Access HIV-1 Test System | Notice | NAL-Notice of Approval | 2010-11-30T05:00:00Z | 2010 | 11 | 2010-11-30T05:00:00Z | 2010-11-30T18:48:05Z | 0 | 0 | 0900006480500b9a | ||
| FDA-2010-N-0594-0001 | FDA | FDA-2010-N-0594 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Focus Groups as Usedby Food and Drug Administration (All Food and Drug Administration Regulated Products) | Notice | N-Notice | 2010-11-30T05:00:00Z | 2010 | 11 | 2010-11-30T05:00:00Z | 2011-02-01T04:59:59Z | 2010-11-30T16:28:27Z | 2010-30037 | 0 | 0 | 0900006480ba9035 |
| FDA-2010-N-0588-0001 | FDA | FDA-2010-N-0588 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Exceptions or Alternatives to Labeling Requirements for Products Held by Strategic National Stockpile | Notice | N-Notice | 2010-11-30T05:00:00Z | 2010 | 11 | 2010-11-30T05:00:00Z | 2011-02-01T04:59:59Z | 2020-10-06T19:47:38Z | 2010-30036 | 0 | 0 | 0900006480ba953f |
| FDA-2010-N-0583-0001 | FDA | FDA-2010-N-0583 | Agency Information Collection Activities: Proposed Collection; Comment Request; Radioactive Drug Research Committees | Notice | 60 Day Proposed Information Collection | 2010-11-30T05:00:00Z | 2010 | 11 | 2010-11-30T05:00:00Z | 2011-02-01T04:59:59Z | 2015-03-09T12:22:51Z | 2010-30038 | 0 | 0 | 0900006480ba90d1 |
| FDA-2010-D-0589-0001 | FDA | FDA-2010-D-0589 | Draft Guidance for Industry on Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Developing Drugs for Treatment; Availability | Notice | NAD-Notice of Availability of Data | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2011-03-01T04:59:59Z | 2011-03-10T20:37:20Z | 2010-29799 | 0 | 0 | 0900006480ba7c22 |
| FDA-2010-N-0600-0001 | FDA | FDA-2010-N-0600 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Animal Drug User Fee Cover Sheet | Notice | 60 Day Proposed Information Collection | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2011-01-29T04:59:59Z | 2017-06-08T13:21:26Z | 2010-29820 | 0 | 0 | 0900006480ba7c1d |
| FDA-2007-D-0150-0008 | FDA | FDA-2007-D-0150 | Guidance for Industry on Antibacterial Drug Products: Use of Noninferiority Studies to Support Approval | Notice | Notice of Availability | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2020-05-06T02:18:14Z | 2010-29796 | 0 | 0 | 0900006480ba7bbf | |
| FDA-2010-D-0590-0001 | FDA | FDA-2010-D-0590 | Guidance for Industry and Food and Drug Administration Staff; Availability, etc.: Blood Lancet Labeling | Notice | NAD-Notice of Availability of Data | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2010-11-30T15:02:35Z | 2010-29795 | 0 | 0 | 0900006480ba7c33 | |
| FDA-2010-M-0361-0002 | FDA | FDA-2010-M-0361 | Medical Devices; Availabilty of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | NAL-Notice of Approval | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2010-11-29T15:04:46Z | 2010-29731 | 0 | 0 | 0900006480ba7e6f | |
| FDA-2010-D-0565-0001 | FDA | FDA-2010-D-0565 | Draft Guidance for Industry and Food and Drug Administration Staff; Availability, etc.: Establishing Performance Characteristics of In Vitro Diagnostic Devices for Detection of Clostridium difficile | Notice | NAD-Notice of Availability of Data | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2011-03-01T04:59:59Z | 2010-11-29T20:19:53Z | 2010-29794 | 0 | 0 | 0900006480ba8169 |
| FDA-2010-D-0584-0001 | FDA | FDA-2010-D-0584 | Guidance for Industry on Abbreviated New Drug Applications; Availability: Impurities in Drug Products | Notice | Notice of Availability | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2020-05-05T20:23:44Z | 2010-29896 | 0 | 0 | 0900006480ba7cc3 | |
| FDA-2010-N-0547-0001 | FDA | FDA-2010-N-0547 | Clinical Development Programs for Sedation Products; Request for Assistance | Notice | N-Notice | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2011-01-29T04:59:59Z | 2024-11-07T22:28:43Z | 2010-29927 | 1 | 0 | 0900006480ba8187 |
| FDA-2010-N-0601-0001 | FDA | FDA-2010-N-0601 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice Regulations for Medicated Feeds | Notice | 60 Day Proposed Information Collection | 2010-11-29T05:00:00Z | 2010 | 11 | 2010-11-29T05:00:00Z | 2011-01-29T04:59:59Z | 2024-11-07T22:28:33Z | 2010-29928 | 1 | 0 | 0900006480ba7ce7 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);